Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Naveau, Sylvie [1 ]
Perlemuter, Gabriel [1 ]
Ziol, Marianne [4 ]
Carmona, Damien [3 ]
Trinchet, Jean Claude [3 ]
Prevot, Sophie [2 ]
Nohra, Pascal [1 ]
Nguefang-Njike, Micheline Nakseu [1 ]
Beaugrand, Michel [3 ]
机构：
[1] Hop Antoine Beclere, Gastroenterol Unit, Clamart, France
[2] Hop Antoine Beclere, Pathol Unit, Clamart, France
[3] Hop Jean Verdier, Gastroenterol Unit, Bondy, France
[4] Hop Jean Verdier, Pathol Unit, Bondy, France
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1506
引用
收藏
页码：898A / 898A
页数：1
相关论文
共 50 条
  • [31] Biomarkers identifying hepatic inflammation in non-alcoholic fatty liver disease (NAFLD)
    Werge, Mikkel
    Hoegl, Annabelle
    Therkelsen, Marie Louise
    Gronborg, Mads
    Mazzoni, Gianluca
    Harder, Lea Morch
    Hvid, Henning
    Rashu, Elias
    Thing, Mira
    Hetland, Liv
    Junker, Anders
    Serizawa, Reza
    Vyberg, Mogens
    Galsgaard, Elisabeth
    Gluud, Lise Lotte
    JOURNAL OF HEPATOLOGY, 2023, 78 : S742 - S743
  • [32] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Rockstroh, Juergen Kurt
    CURRENT HIV/AIDS REPORTS, 2017, 14 (02) : 47 - 53
  • [33] miR-101 IN STEATOSIS AND STEATOHEPATITIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Elfimova, N.
    Ommer, K.
    Schlattjan, M.
    Sowa, J. P.
    Wedemeyer, I.
    Vantler, M.
    Dienes, H. P.
    Canbay, A.
    Odenthal, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S508 - S508
  • [34] Progenitor cell activation in alcoholic (ALD) and in non-alcoholic fatty liver disease (NAFLD): An immunohistochemical and ultrastructural study
    Durnez, AMT
    De Vos, R
    Verslype, C
    Roskams, T
    JOURNAL OF HEPATOLOGY, 2003, 38 : 193 - 193
  • [35] Similarities and differences between non-alcoholic fatty liver disease (NAFLD) & alcohol-associated liver disease (ALD)
    Singal, Ashwani K.
    TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 6
  • [36] Other disease associations with non-alcoholic fatty liver disease (NAFLD)
    Allard, JP
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) : 783 - 795
  • [37] Body mass index–based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease
    Ramesh Shalimar
    Gyanranjan Kumar
    Rahul Rout
    Rajini Kumar
    Prasenjit Yadav
    Sandeep Das
    Deepak Aggarwal
    Anoop Gunjan
    Baibaswata Saraya
    Indian Journal of Gastroenterology, 2020, 39 : 32 - 41
  • [38] Non-alcoholic Fatty Liver Disease Diagnosis and Therapy of NAFLD
    不详
    GASTROENTEROLOGE, 2021, 16 (05): : 386 - 386
  • [39] A lipidomic analysis of non-alcoholic fatty liver disease (NAFLD)
    Puri, P.
    Baillie, R. A.
    Wiest, M.
    Mirshahi, F.
    Sanyal, A. J.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S260 - S261
  • [40] Irisin Is Related to Non-Alcoholic Fatty Liver Disease (NAFLD)
    Kosmalski, Marcin
    Drzewoski, Jozef
    Szymczak-Pajor, Izabela
    Zieleniak, Andrzej
    Mikolajczyk-Solinska, Melania
    Kasznicki, Jacek
    Sliwinska, Agnieszka
    BIOMEDICINES, 2022, 10 (09)
12345